Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
01
The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
02
Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer
03
All the Right Ingredients: A Q&A with the Founders of ArsenalBio
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
We combined forces with the brightest minds in the field to radically change the way research is done – to save lives faster.
Our model is designed to remove barriers, encourage collaboration and turn ideas into real-world cancer treatments.
80+
Research collaborators
142
Pici-Supported research Projects
TREATMENT AGENTS STUDIED
300+
Patients treated
Industry and nonprofit collaborations
7
strategic investments
One-on-one collaboraTIVE DATA PROJECTS
17K
PATIENTS’ DATA ANALYZED
invention disclosures Reviewed
149
Inventions supported
Biospecimens collected
18
Translational suite assays